On May 5, 2026, the U.S. FDA's "Guidance on Digital Compliance Disclosure of Food Contact Substances (FCS)" officially came into effect. This requirement directly impacts Chinese suppliers exporting food contact products such as food packaging, kitchenware, and smart catering equipment to the U.S., particularly setting clear new standards for B2B website technical compliance capabilities. Relevant companies must immediately assess the compatibility of their existing website architecture with their export business.

Event Overview

On May 5, 2026, the U.S. FDA officially implemented the "Guidance on Digital Compliance Disclosure of Food Contact Substances (FCS)". According to this guidance, all Chinese suppliers exporting food contact products (including food packaging, kitchenware, and smart catering equipment) to the U.S. must embed a multilingual (English, Spanish, French) compliance verification portal on their official B2B websites within the corresponding product pages. This portal must support real-time retrieval of FDA registration numbers, Declarations of Conformity (DoCs), and third-party testing reports, and be compatible with QR code scanning and API integration. Websites that fail to meet this requirement may impact import customs clearance efficiency and reduce the trust of overseas buyers.

Which sub-sectors will be affected?

Direct trading enterprises

For trading companies that export food contact products directly to US importers, retailers, or e-commerce platforms under their own brands or through OEM arrangements, their official websites are the primary channel for buyers to verify compliance. The impact is as follows: buyers will prioritize checking the availability of the website verification portal before conducting factory inspections; the lack of this function may lead to a decrease in inquiry conversion rates, delayed order confirmations, or even requests for supplementary offline documents, increasing transaction friction costs.

Processing and manufacturing enterprises

Factories that manufacture food contact products for overseas brands (such as injection-molded kitchenware factories, metal tableware factories, and smart thermos cup manufacturers) must bear the responsibility of disclosing compliance information on their official websites if they complete FDA registration and issue a DoC in their own name. The impact is that the inability to independently provide a verifiable digital compliance path will weaken their market recognition as a "compliant supplier," affecting their bargaining power in the international supply chain and their eligibility for customer access.

Raw material procurement companies

Companies that supply key raw materials such as polymer materials, coating additives, and food-grade silicone to downstream food contact product manufacturers, even if they do not directly export end products, must have their material compliance data (such as migration test reports and substance lists) integrated into the DoC (Document of Conformity) of downstream products. The impact is that downstream customers may require these companies to provide verifiable raw material-level compliance information interfaces on their official websites; otherwise, it will be difficult to meet the end-to-end traceability disclosure requirements for complete machines/packaged products.

Supply chain service companies

Third-party agencies providing FDA registration agency services, test report integration, compliance consulting, and multilingual website development services will face changes in customer demand. The impact is reflected in the shift in customer inquiries from "whether registration is possible" to "how to make registration information verifiable by buyers with a single click," requiring service delivery to cover new aspects such as front-end webpage embedding, back-end API integration, and multilingual content management.

What key areas should relevant businesses or practitioners focus on, and how should they respond at present?

Confirm whether you are a subject to the guidelines

The criteria for judgment are: whether the company has completed FDA Food Contact Substances (FCS) registration (i.e., holds an FDA registration number), and whether the products covered by that registration number are actually sold in the United States. Companies that are merely contract manufacturers but have not participated in the registration or signed the DoC are not currently considered directly obligated entities, but they must cooperate with the brand to provide the required compliance data.

Verify the technical feasibility of the product page on the official website.

The key checks should focus on whether existing B2B websites support dynamic embedded components (such as iframes or micro-frontend modules), whether they have a multilingual content management system (CMS), and whether they have reserved API integration permissions. Avoid relying on one-time static page updates; ensure that the verification entry content can be synchronized in real-time with registration status and the validity period of the test report.

Distinguishing between policy-mandated nodes and commercially trusted nodes

The FDA has not established a unified technical platform or designated third-party verification service providers, nor has it announced any proactive inspections of official websites. Currently, it should be understood that while this requirement has not yet formed a mandatory customs interception mechanism, it has become a de facto due diligence step for large importers, chain restaurant groups, and mainstream e-commerce platforms. A compliant official website has become an implicit barrier in B2B procurement decisions.

Prioritize the revamp of pages corresponding to high-value product categories and key customers.

No need for a site-wide simultaneous launch. It is recommended to sort by export value and prioritize the page revamp of the top 10% of product lines by annual export value to the US (such as aluminum foil lunch boxes, silicone baking molds, and smart coffee machine shells); at the same time, review the review practices of the top 5 US customer websites and optimize the response logic of verification entry points and language switching experience under their frequently accessed paths.

Editor's Viewpoint / Industry Observation

Observably, this guidance does not introduce new regulatory approval requirements, but rather transforms existing FDA registration and declaration obligations into a digitally verifiable form for downstream purchasers. It's more like a "signal of increased compliance visibility" than an immediate enforcement tool. Analysis shows that its core intention is to reduce information asymmetry, lower compliance due diligence costs for importers, and force upstream suppliers to improve their transparency management. Currently, the industry needs to continuously monitor whether the FDA will integrate this verification portal into its public database (such as the FURLS system) for cross-validation; and whether major US retail channels (such as Walmart and Target) will include it as a mandatory option in their online supplier onboarding audits.

In conclusion, this new regulation marks a shift in compliance for food contact product exports from a "documentary compliance" stage to a "verifiable compliance" stage. Its industry significance lies not in creating additional licensing barriers, but in reshaping how trust is built in cross-border procurement—credibility is no longer solely endorsed by paper documents, but rather reflected in real-time interactive digital interfaces. Currently, it is more accurately understood as an upgrade in compliance expression for the procurement end. Companies should proceed with technological adaptation at a pragmatic pace, focusing on ensuring information accessibility and language accuracy along key customer access paths, rather than pursuing immediate compliance across the entire website.

The information source is primarily the "Food Contact Substances (FCS) Digital Compliance Disclosure Guidance" published on the U.S. FDA website (2026 version, effective date specified as May 5, 2026).
The following aspects require continued observation: whether the FDA will release supporting technical specifications (such as API interface standards and multilingual content format requirements), and whether it will collaborate with U.S. Customs and Border Protection (CBP) to update joint guidance.